Sharekhan by BNP Paribas gives a buy recommendation for Sun Pharmaceutical Industries Ltd., targeting Rs 2264, with the current market price at Rs 1785.6. For the quarter ending September 2024, the company reported a total income of Rs 13645.39 crore and a net profit of Rs 3030.67 crore. Promoters hold a 54.48% stake.
